The rockefeller university

A remarkable correspondence exists between lattices generated by discrete Jordan algebras and symmetries of superstrings, strongly suggesting that all known superstring theories are related and descend from a more general theory related to the Conway-Sloane transhyperbolic group. Cartan tori has visible spaces and G/H Cartan generators as dark builders of G and determined by root lattices. E-10 is shown as the dark group of the visible (9 + 1) space time with the Lorentz group O(9 + 1). Embedding of the higher exceptional groups will also be presented.

Herpes simplex virus type 1 (HSV-1) encephalitis (HSE) is the most common sporadic viral encephalitis in Western countries. Some HSE children carry inborn errors of the Toll-like receptor 3 (TLR3)-dependent IFN-alpha/beta and -lambda-inducing pathway. Induced pluripotent stem cell (iPSC)-derived cortical neurons with TLR3 pathway mutations are highly susceptible to HSV-1, due to impairment of cell-intrinsic TLR3-IFN immunity. In contrast, the contribution of cell-intrinsic immunity of human trigeminal ganglion (TG) neurons remains unclear. Here, we describe efficient in vitro derivation and purification of TG neurons from human iPSCs via a cranial placode intermediate. The resulting TG neurons are of sensory identity and exhibit robust responses to heat (capsaicin), cold (icilin), and inflammatory pain (ATP). Unlike control cortical neurons, both control and TLR3-deficient TG neurons were highly susceptible to HSV-1. However, pretreatment of control TG neurons with poly(I:C) induced the cells into an anti HSV-1 state. Moreover, both control and TLR3-deficient TG neurons developed resistance to HSV-1 following pretreatment with IFN-beta but not IFN-lambda. These data indicate that TG neurons are vulnerable to HSV-1 because they require preemptive stimulation of the TLR3 or IFN-alpha/beta receptors to induce antiviral immunity, whereas cortical neurons possess a TLR3-dependent constitutive resistance that is sufficient to block incoming HSV-1 in the absence of prior antiviral signals. The lack of constitutive resistance in TG neurons in vitro is consistent with their exploitation as a latent virus reservoir in vivo. Our results incriminate deficiencies in the constitutive TLR3-dependent response of cortical neurons in the pathogenesis of HSE.

Shigella flexneri, an intracellular Gram-negative bacterium causative for shigellosis, employs a type III secretion system to deliver virulence effectors into host cells. One such effector, IcsB, is critical for S. flexneri intracellular survival and pathogenesis, but its mechanism of action is unknown. Here, we discover that IcsB is an 18-carbon fatty acyltransferase catalysing lysine N-epsilon-fatty acylation. IcsB disrupted the actin cytoskeleton in eukaryotes, resulting from N-epsilon-fatty acylation of RhoGTPases on lysine residues in their polybasic region. Chemical proteomic profiling identified about 60 additional targets modified by IcsB during infection, which were validated by biochemical assays. Most IcsB targets are membrane-associated proteins bearing a lysine-rich polybasic region, including members of the Ras, Rho and Rab families of small GTPases. IcsB also modifies SNARE proteins and other non-GTPase substrates, suggesting an extensive interplay between S. flexneri and host membrane trafficking. IcsB is localized on the Shigella-containing vacuole to fatty-acylate its targets. Knockout of CHMP5-one of the IcsB targets and a component of the ESCRT-III complex-specifically affected S. flexneri escape from host autophagy. The unique N-epsilon-fatty acyltransferase activity of IcsB and its altering of the fatty acylation landscape of host membrane proteomes represent an unprecedented mechanism in bacterial pathogenesis.

Unmanned aerial systems (UASs) are powerful tools for research and monitoring of wildlife. However, the effects of these systems on most marine mammals are largely unknown, preventing the establishment of guidelines that will minimize animal disturbance. In this study, we evaluated the behavioral responses of coastal bottlenose dolphins (Tursiops truncatus) and Antillean manatees (Trichechus manatus manatus) to small multi-rotor UAS flight. From 2015 to 2017, we piloted 211 flights using DJI quadcopters (Phantom II Vision +, 3 Professional and 4) to approach and follow animals over shallow-water habitats in Belize. The quadcopters were equipped with high-resolution cameras to observe dolphins during 138 of these flights, and manatees during 73 flights. Aerial video observations of animal behavior were coded and paired with flight data to determine whether animal activity and/or the UAS's flight patterns caused behavioral changes in exposed animals. Dolphins responded to UAS flight at altitudes of 11-30 m and responded primarily when they were alone or in small groups. Single dolphins and one pair responded to the UAS by orienting upward and turning toward the aircraft to observe it, before quickly returning to their pre-response activity. A higher number of manatees responded to the UAS, exhibiting strong disturbance in response to the aircraft from 6 to 104 m. Manatees changed their behavior by fleeing the area and sometimes this elicited the same response in nearby animals. If pursued post-response, manatees repeatedly responded to overhead flight by evading the aircraft's path. These findings suggest that the invasiveness of UAS varies across individuals, species, and taxa. We conclude that careful exploratory research is needed to determine the impact of multi-rotor UAS flight on diverse species, and to develop best practices aimed at reducing the disturbance to wildlife that may result from their use.

Individuals infected with HIV-1 require lifelong antiretroviral therapy, because interruption of treatment leads to rapid rebound viraemia. Here we report on a phase 1b clinical trial in which a combination of 3BNC117 and 10-1074, two potent monoclonal anti-HIV-1 broadly neutralizing antibodies that target independent sites on the HIV-1 envelope spike, was administered during analytical treatment interruption. Participants received three infusions of 30 mg kg(-1) of each antibody at 0, 3 and 6 weeks. Infusions of the two antibodies were generally well-tolerated. The nine enrolled individuals with antibody-sensitive latent viral reservoirs maintained suppression for between 15 and more than 30 weeks (median of 21 weeks), and none developed viruses that were resistant to both antibodies. We conclude that the combination of the anti-HIV-1 monoclonal antibodies 3BNC117 and 10-1074 can maintain long-term suppression in the absence of antiretroviral therapy in individuals with antibody-sensitive viral reservoirs.

Human inborn errors of IFN-gamma immunity underlie mycobacterial diseases. We describe patients with Mycobacterium bovis (BCG) disease who are homozygous for loss-of-function mutations of SPPL2A. This gene encodes a transmembrane protease that degrades the N-terminal fragment (NTF) of CD74 (HLA invariant chain) in antigen-presenting cells. The CD74 NTF therefore accumulates in the HLA class II+ myeloid and lymphoid cells of SPPL2a-deficient patients. This toxic fragment selectively depletes IL-12-and IL-23-producing CD1c(+) conventional dendritic cells (cDC2s) and their circulating progenitors. Moreover, SPPL2a-deficient memory T(H)1(star) cells selectively fail to produce IFN-gamma when stimulated with mycobacterial antigens in vitro. Finally, Sppl2a(-/-) mice lack cDC2s, have CD4(+) T cells that produce small amounts of IFN-gamma after BCG infection, and are highly susceptible to infection with BCG or Mycobacterium tuberculosis. These findings suggest that inherited SPPL2a deficiency in humans underlies mycobacterial disease by decreasing the numbers of cDC2s and impairing IFN-gamma production by mycobacterium-specific memory T(H)1(star) cells.

Linker histone H1 has a key role inmaintaining higher order chromatin structure and genome stability, but how H1 functions in these processes is elusive. Here, we report that acetylation of lysine 85 (K85) within the H1 globular domain is a critical post-translational modification that regulates chromatin organization. H1K85 is dynamically acetylated by the acetyltransferase PCAF in response to DNA damage, and this effect is counterbalanced by the histone deacetylase HDAC1. Notably, an acetylation-mimic mutation of H1K85 (H1K85Q) alters H1 binding to the nucleosome and leads to condensed chromatin as a result of increased H1 binding to core histones. In addition, H1K85 acetylation promotes heterochromatin protein 1 (HP1) recruitment to facilitate chromatin compaction. Consequently, H1K85 mutation leads to genomic instability and decreased cell survival upon DNA damage. Together, our data suggest a novel model whereby H1K85 acetylation regulates chromatin structure and preserves chromosome integrity upon DNA damage.

N-6-methyladenosine (m(6)A), the most prevalent internal methylation in messenger RNA (mRNA) that is deposited by m(6)A methyltransferases, removed by m(6)A demethylases and recognized by different RNA binding proteins, distinguishes the transcripts through multilayer interactions with mRNA processing, export, degradation and translation machineries. m(6)A plays an important role in regulation of gene expression for fundamental cellular processes and diverse physiological functions. Aberrant m(6)A decorations lead to cancer but also have the potential to yield new therapies. This review outlines the evolution of the m(6)A field, formation of key concepts, important open questions and also discusses the molecular basis of mRNA m(6)A modification and its effect in cancer, highlighting the potential of demethylase as a therapeutic target for cancer treatment. (C) 2018 Elsevier Inc. All rights reserved.